Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs VIVIMED LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA VIVIMED LABS ASTRAZENECA PHARMA/
VIVIMED LABS
 
P/E (TTM) x 97.2 -0.1 - View Chart
P/BV x 23.1 1.0 2,241.3% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ASTRAZENECA PHARMA   VIVIMED LABS
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
VIVIMED LABS
Mar-23
ASTRAZENECA PHARMA/
VIVIMED LABS
5-Yr Chart
Click to enlarge
High Rs3,62017 20,838.8%   
Low Rs2,4387 36,548.0%   
Sales per share (Unadj.) Rs401.222.6 1,777.8%  
Earnings per share (Unadj.) Rs39.7-39.6 -100.2%  
Cash flow per share (Unadj.) Rs46.2-26.5 -174.1%  
Dividends per share (Unadj.) Rs16.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs234.44.8 4,930.8%  
Shares outstanding (eoy) m25.0082.91 30.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.50.5 1,417.3%   
Avg P/E ratio x76.3-0.3 -25,138.6%  
P/CF ratio (eoy) x65.5-0.5 -14,473.4%  
Price / Book Value ratio x12.92.5 511.0%  
Dividend payout %40.30-   
Avg Mkt Cap Rs m75,718997 7,597.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,591327 793.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,0301,871 536.1%  
Other income Rs m26110 2,696.3%   
Total revenues Rs m10,2911,881 547.2%   
Gross profit Rs m1,249-1,870 -66.8%  
Depreciation Rs m1631,084 15.0%   
Interest Rs m6362 1.7%   
Profit before tax Rs m1,341-3,307 -40.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m348-21 -1,644.3%   
Profit after tax Rs m993-3,285 -30.2%  
Gross profit margin %12.5-99.9 -12.5%  
Effective tax rate %26.00.6 4,054.4%   
Net profit margin %9.9-175.6 -5.6%  
BALANCE SHEET DATA
Current assets Rs m9,3593,323 281.7%   
Current liabilities Rs m4,8444,243 114.2%   
Net working cap to sales %45.0-49.2 -91.5%  
Current ratio x1.90.8 246.7%  
Inventory Days Days49389 12.7%  
Debtors Days Days39150 26.1%  
Net fixed assets Rs m2,0616,561 31.4%   
Share capital Rs m50166 30.2%   
"Free" reserves Rs m5,811228 2,544.4%   
Net worth Rs m5,861394 1,486.8%   
Long term debt Rs m0623 0.0%   
Total assets Rs m11,4219,883 115.6%  
Interest coverage x213.9-8.1 -2,631.4%   
Debt to equity ratio x01.6 0.0%  
Sales to assets ratio x0.90.2 463.9%   
Return on assets %8.7-29.6 -29.6%  
Return on equity %16.9-833.4 -2.0%  
Return on capital %23.0-289.4 -7.9%  
Exports to sales %00.9 0.0%   
Imports to sales %37.40-   
Exports (fob) Rs mNA17 0.0%   
Imports (cif) Rs m3,747NA-   
Fx inflow Rs m61217 3,697.9%   
Fx outflow Rs m3,7470-   
Net fx Rs m-3,13517 -18,942.6%   
CASH FLOW
From Operations Rs m583353 165.0%  
From Investments Rs m181-50 -364.5%  
From Financial Activity Rs m-245-338 72.5%  
Net Cashflow Rs m519-34 -1,517.2%  

Share Holding

Indian Promoters % 75.0 20.9 358.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 6.5 1.8 369.3%  
FIIs % 2.7 1.6 166.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 79.1 31.6%  
Shareholders   29,418 49,027 60.0%  
Pledged promoter(s) holding % 0.0 37.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs VIVIMED LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs VIVIMED LABS Share Price Performance

Period ASTRAZENECA PHARMA VIVIMED LABS S&P BSE HEALTHCARE
1-Day 2.18% -3.92% 0.45%
1-Month 7.03% -10.42% 2.55%
1-Year 71.09% -52.88% 56.14%
3-Year CAGR 7.93% -22.63% 15.22%
5-Year CAGR 18.46% -38.72% 19.63%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the VIVIMED LABS share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of VIVIMED LABS the stake stands at 20.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of VIVIMED LABS.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

VIVIMED LABS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of VIVIMED LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.